Orange Book product · Brand (NDA)
POTASSIUM CITRATE
POTASSIUM CITRATE
At a glance
Oct 13, 1988
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 13, 1988
38 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
POTASSIUM CITRATE
Strength
20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
FOR SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 019647
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1985UROCIT-KBrand (NDA)
NDA 019071 · MISSION PHARMA
- 2024POTASSIUM CITRATEGeneric (ANDA)
ANDA 213986 · TORRENT
- 2021POTASSIUM CITRATEGeneric (ANDA)
ANDA 214426 · HIBROW HLTHCARE
- 2021POTASSIUM CITRATEGeneric (ANDA)
ANDA 214420 · ASCENT PHARMS INC
- 2020POTASSIUM CITRATEGeneric (ANDA)
ANDA 212799 · BIONPHARMA
- 2020POTASSIUM CITRATEGeneric (ANDA)
ANDA 212779 · ANI PHARMS
- 2018POTASSIUM CITRATEGeneric (ANDA)
ANDA 209758 · TEVA PHARMS USA INC
- 2017POTASSIUM CITRATEGeneric (ANDA)
ANDA 206813 · STRIDES PHARMA
- 2014POTASSIUM CITRATEGeneric (ANDA)
ANDA 203546 · ZYDUS PHARMS
- 2006POTASSIUM CITRATEGeneric (ANDA)
ANDA 077440 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
